All Stories

  1. Genotyping on circulating tumor DNA improves mutation detection rate in high-risk diffuse large B-cell lymphoma

    Article • Genes & Diseases, July 2024, Tsinghua University Press

    Wei Xu

  2. Bortezomib depended on PRDM1 and TP53 to exert therapeutic effect in activated B-cell-like diffuse large B-cell lymphoma

    Article • Genes & Diseases, March 2024, Tsinghua University Press

    Wei Xu

  3. EBV-Mir-BART5-5p targets p53 independent pathway in cytoplasm: Potential role in EBV lymphomagenesis

    Article • Genes & Diseases, July 2023, Tsinghua University Press

    Wei Xu

  4. Low absolute NK cell counts in peripheral blood are associated with inferior survival in patients with mantle cell lymphoma

    Article • Cancer Biomarkers, April 2019, IOS Press

    Wei Xu

  5. Diabetes mellitus predicts inferior survival in diffuse large B-cell lymphoma: a propensity score-matched analysis

    Article • Cancer Management and Research, April 2019, Dove Medical Press

    Wei Xu, Tao Yang

  6. Low serum cholesterol levels predict inferior prognosis and improve NCCN-IPI scoring in diffuse large B cell lymphoma

    Article • International Journal of Cancer, August 2018, Wiley

    Wei Xu

  7. Definition of disease-progression risk stratification in untreated chronic lymphocytic leukemia using combined clinical, molecular and virological variables

    Article • Hematological Oncology, June 2018, Wiley

    Wei Xu

  8. NOTCH1 mutation and its prognostic significance in Chinese chronic lymphocytic leukemia: a retrospective study of 317 cases

    Article • Cancer Medicine, March 2018, Wiley

    Wei Xu

  9. Low T3 syndrome as a predictor of poor prognosis in chronic lymphocytic leukemia

    Article • International Journal of Cancer, March 2018, Wiley

    Wei Xu

  10. Spectrum and immunophenotyping of 653 patients with B-cell chronic lymphoproliferative disorders in China: A single-centre analysis

    Article • Hematological Oncology, July 2017, Wiley

    Wei Xu

  11. Enemies or weapons in hands: investigational anti-diabetic drug glibenclamide and cancer risk

    Article • Expert Opinion on Investigational Drugs, June 2017, Taylor & Francis

    Wei Xu, Tao Yang

  12. Prognostic significance of serum immunoglobulin paraprotein in patients with diffuse large B cell lymphoma

    Article • British Journal of Haematology, May 2017, Wiley

    Wei Xu

  13. Low T3 syndrome is a strong prognostic predictor in diffuse large B cell lymphoma

    Article • British Journal of Haematology, February 2017, Wiley

    Wei Xu

  14. Negative prognostic impact of low absolute CD4+T cell counts in peripheral blood in mantle cell lymphoma

    Article • Cancer Science, September 2016, Wiley

    Wei Xu

  15. Serum carbohydrate antigen 125 concentration as a superior predictor for serosal effusion at diagnosis and a prognostic factor in diffuse large B-cell lymphoma

    Article • Cancer Biomarkers, August 2016, IOS Press

    Wei Xu